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Abstract
The present study analyzed serum samples from 111 male and female dogs of various ages from the municipality 
of Araguaína in the State of Tocantins, Brazil. Serological diagnosis of canine visceral leishmaniasis (CVL) was initially 
performed at the Central Laboratory (Laboratório Central – LACEN) of Araguaína, resulting in 61 positive samples 
by an indirect immunofluorescence assay (IIFA) (≥1:40) and 50 non-reactive samples. The same samples were analyzed 
at the São Paulo Institute of Tropical Medicine (Instituto de Medicina Tropical de São Paulo – IMTSP) by an enzyme-
linked-immunosorbent assay (ELISA), resulting in 57 positive samples (51.35%) and 54 negative samples (48.64%). 
The Kappa coefficient of agreement between the tests was 0.74. The serum samples were also subjected to a diagnostic 
assay for Trypanosoma cruzi (Trypomastigote Excreted/Secreted Antigens -TESA-blot) that detected five suspect animals; 
three of those animals were positive for leishmaniasis by ELISA but negative by IIFA. These findings suggest that the 
canine population of Araguaína may be simultaneously infected with Leishmania chagasi and T. cruzi. The results 
obtained demonstrate the difficulty of using serology to detect CVL, thus emphasizing the necessity for a reference test 
to diagnose CVL, particularly in regions where the infection is endemic.
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Resumo
Neste estudo foram analisadas amostras de soros de 111 cães machos e fêmeas, de idades variadas, provenientes 
do município de Araguaína, estado do Tocantins, Brasil. O diagnóstico sorológico para leishmaniose visceral canina 
foi realizado, inicialmente, no Laboratório Central (LACEN) de Araguaína, resultando em 61 amostras positivas 
na Reação de Imunofluorescência Indireta  -  RIFI (≥1:40) e 50 amostras não reativas. As mesmas amostras foram 
analisadas no Instituto de Medicina Tropical de São Paulo (IMTSP) pelo Enzyme-Linked-Immunosorbent Assay 
(ELISA), sendo 57 amostras positivas (51,35%) e 54 amostras negativas (48,64%), com coeficiente de concordância 
entre os testes (Kappa = 0,74). Os soros foram submetidos também a um teste de diagnóstico para Trypanosoma cruzi 
(Trypomastigote Excreted/Secreted Antigens -TESA-blot), o qual detectou cinco animais suspeitos, dos quais três foram 
positivos para leishmaniose no ELISA, mas negativos na RIFI. Estas observações mostram que a população canina de 
Araguaína pode também estar infectada simultaneamente com Leishmania chagasi e T. cruzi. Estes resultados mostram 
a dificuldade da sorologia na detecção da Leishmaniose Visceral Canina (LVC), reforçando a necessidade de um teste de 
referência para o diagnóstico da leishmaniose visceral canina, principalmente em regiões endêmicas para tais infecções.
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Introduction
Canine visceral leishmaniasis (CVL), also known as “kala-azar,” 
is an infection caused by protozoa that are transmitted to animals 
and humans through the bite of an insect vector (DIETZE; 
CARVALHO, 2003). The etiological agent is an intracellular 
parasite of the genus Leishmania and the complex Leishmania 
(Leishmania) donovani that is known in the Americas as L. chagasi 
and transmitted by the phlebotomine Lutzomyia longipalpis 
(LUTZ; NEIVA, 1912; SANTOS, et al., 1998). In northern and 
northeastern Brazil, the vector is found in the forests and is part 
of the primary transmission cycle for the illness. L. longipalpis can 
adapt to various environments, and its population density is greater 
inside and around human habitations, which promotes disease 
transmission (BARATA et al., 2005). Other species including 
ducks, rodents, passerines, and chickens are considered risk factors 
for CVL transmission in these regions (BORGES et al., 2009).
The main clinical symptoms of CVL are as follows: development 
of skin lesions; periocular alopecia; nasal and/or auricular ulcers; 
fever; weight loss; lymphadenopathy; epistaxis; onychogryphosis; 
splenomegaly; conjunctivitis; emaciation; signs of renal failure, 
such as polyuria, polydipsia, and vomiting; neuralgia; polyarthritis; 
polymyositis; osteolytic lesions; and proliferative periostitis 
(MONTEIRO et al., 2009). Clinical diagnosis of CVL is difficult 
due to the myriad clinical symptoms that may be exhibited 
by apparently healthy animals, oligosymptomatic animals, 
and animals at advanced disease stages (GONTIJO; MELO, 
2004). Various diagnostic assays are available, but they vary in 
sensitivity as a function of the clinical condition, parasite density, 
biological material, and the diagnostic methods used for analysis 
(BISUGO et al., 2007). The tests most commonly used to diagnose 
human visceral leishmaniasis (HVL) and CVL in Brazil are the 
indirect immunofluorescence assay (IIFA) and the enzyme-linked-
immunosorbent assay (ELISA).
ELISA is considered a screening method for CVL diagnosis 
because it is rapid and can be automated for high throughput. 
Additionally, ELISA has 71% to 100% sensitivity and 85% to 
100% specificity (ALVES; BEVILACQUA, 2004); the antigen 
(crude or recombinant) and protocol used can affect these rates. 
The use of crude or total antigen limits the specificity of ELISA 
and produces cross reactivity with other trypanosomatids or even 
phylogenetically distant organisms (PEDROSO, 2010).
IIFA is the test of choice for epidemiological surveys because 
it offers multiple advantages including low cost, high speed, and 
ease of use (ALVES; BEVILACQUA, 2004). IIFA results are 
expressed as titers and are considered positive starting at 1:40. The 
sensitivity of IIFA ranges from 68% to 100%, with 74% to 100% 
specificity. Similar to ELISA, IIFA produces cross-reactivity with 
samples from hosts infected by T. cruzi because of the phylogenetic 
proximity between the parasites (ALVES; BEVILACQUA, 2004; 
GONTIJO; MELO, 2004; ASSIS,2010). Antigens derived from 
promastigote forms may feature antigenic epitopes that are shared 
with other species of the family Trypanosomatidae, especially T. cruzi 
(SUNDAR; RAI, 2002). Such cross-reactions can be minimized 
by using purified or recombinant antigens. Purified antigens have 
shown better sensitivity than crude antigens, but preparation of 
the former is much slower and may require more sophisticated 
purification methods. Several recombinant antigens are already 
available for diagnosing HVL and CVL (GONTIJO; MELO, 
2004). Thus, a requirement exists for confirmatory LV tests, such 
as parasitology methods and PCR. Although the parasitological 
method is specific, it has the disadvantages of being difficult to 
use in epidemiological surveys and being more invasive because 
puncture of the bone marrow or lymph node is required. Moreover, 
the method is less sensitive, yielding approximately 60% sensitivity 
for bone marrow smears and 30% sensitivity for lymph node 
smears. PCR is becoming increasingly useful for diagnosing VL 
because this technique more accurately detects the seronegative 
population and has almost completely overcome the limitations 
of serological techniques by providing faster speeds with greater 
specificity and sensitivity, even in asymptomatic patients (FEITOSA 
et al., 2000). The limitations on using PCR for epidemiological 
surveys are the cost, availability of reagents and equipment, and 
poor field adaptability (ALVES; BEVILACQUA, 2004). Thus, 
whenever using serological diagnosis for CVL, it is important 
to perform a differential diagnosis that includes Chagas disease 
(CD) while remaining attentive to the clinical signs exhibited 
by the animal, if present, and epidemiological aspects, including 
the point of origin (whether the area is endemic for leishmaniasis 
or CD), presence of vectors (phlebotomine for leishmaniasis 
and triatomine for CD), and contact between the dog and wild 
animals, which are major reservoirs of both Leishmania spp. and 
T. cruzi (LUCIANO et al., 2009).
CD, or American trypanosomiasis, is a zoonotic disease resulting 
from infection by the protozoan T. cruzi, which is transmitted by 
a hematophagous insect of the genus Triatoma that is commonly 
known as the “barber bug” or “kissing bug” and inhabits cracks 
in clay or wooden walls (REY, 2008). CD is endemic to various 
Latin American countries and is transmitted through vectors, blood 
transfusions, consuming contaminated foods, breast-feeding, or 
the transplacental route (REY, 2008).
Wild and domestic animals, including dogs, are major reservoirs 
of CD and can promote disease transmission (COHEN; GURTLER, 
2001). Diagnosis of CD also relies on the use of serological assays 
such as IIFA, ELISA, and the hemagglutination inhibition (HAI) 
assay. More complex tests such as PCR and the western blot (WB) 
can be used for confirmation of both the acute and chronic forms 
of CD (GOMES, 2004; PINTO, 2009).
A study conducted by Correa (2010) from 2008 to 2010 in 
the Cardiology Outpatient Clinic of Araguaína – TO found a 
prevalence of 9.5% for CD in human patients, confirming the 
presence of the etiological agent for CD in the municipality 
under study. Thus, canine infection by T. cruzi at the investigated 
location is possible. The potential for CVL false-positives should 
be considered because they may lead to erroneous diagnoses and 
improper recommendations for euthanasia of the specified dogs.
Because Araguaína – TO has been designated a priority 
municipality for monitoring and control of visceral leishmaniasis 
(VL) in Brazil, according to the average number of cases from 
2008 to 2010 (BRASIL, 2010), and because there are confirmed 
human cases of CD demonstrating the presence of the etiological 
agent in the region, the purpose of the present study was to test 
for serological cross-reactivity between antigens for L. chagasi 
and T. cruzi, which could yield false positives for CVL in sero-
epidemiological surveys. An additional aim was to investigate the 
status of CD among the canine population in Araguaína – TO.
226
Canine leishmaniasis and Chagas disease in Araguaina
Materials and Methods
Serum sampling
IgG antibodies against L. chagasi and against T. cruzi were 
studied in serum samples from 111 dogs from the municipality 
of Araguaína – Tocantins, which is endemic for CVL and CD. 
All of the samples were provided by the Center for Control of 
Zoonotic Diseases of the municipality of Araguaína – TO and 
initially analyzed by IIFA at the Central Laboratory (Laboratório 
Central – LACEN) of Araguaína – TO. The same samples were 
subsequently sent to the Protozoology Laboratory at the São Paulo 
Institute for Tropical Medicine of the University of São Paulo 
(Universidade de São Paulo – USP), which is a reference center 
for CD diagnosis, and were subjected to ELISA for the detection 
of anti-Leishmania antibodies, followed by a TESA-blot for the 
detection of anti-T. cruzi antibodies.
Serological tests
IIFA
IIFA was performed at LACEN in Araguaína – TO using a 
commercial kit (Biomanguinhos®) according to the manufacturer’s 
instructions.
ELISA
ELISA was performed in the Protozoology Laboratory at the 
São Paulo Institute for Tropical Medicine – USP. Promastigotes 
of L. chagasi, strain MHOM/BR/1972/LD, were obtained from 
cultures in liquid RPMI medium containing 10% fetal serum. The 
parasites were concentrated by centrifugation at 2,500 rpm for 10 
minutes, and the suspensions obtained were immediately frozen 
and stored at -80°C. To prepare the soluble antigen, promastigotes 
were suspended in 10 volumes of lysis buffer (0.05 M TRIS-HCL, 
pH 6.0; 4 M Urea; 5 mM EDTA; 0.5 mM PMSF; 0.1 M KCL; 
and 0.5% SDS), heated to 65 °C for 15 minutes, and centrifuged 
at 10,000 rpm. The protein concentration of the soluble antigen 
was measured from the supernatant by the Bradford method, and 
the prepared antigen was aliquoted and stored at –80 ºC. High-
binding polystyrene Costar plates (Corning, USA) were used for 
the ELISA. The plates were sensitized with 10 mg/mL of L. chagasi 
(50 mL/well) diluted in 0.05 M carbonate-bicarbonate buffer 
(pH 9.6). After blocking with 5% skim milk (Molico, Nestlé), 
50 mL of serum (1:200) were added to the plates. After being 
incubated and washed, the plates received 50 mL of peroxidase-
conjugated dog anti-IgG (Sigma Co, EUA). The antigen-antibody 
complex was visualized by addition of a chromogenic substrate 
(5 mg ortho-phenylenediamine – OPD; 7.5 mL 30% hydrogen 
peroxide – H2O2; 12 mL 0.05 M citrate-citric acid buffer, pH 
5.0) and interrupted by the addition of 25 mL 4 N HCL. The 
optical density was obtained on an ELISA reader (Multiskan-
Titertek II) at 492 nm.
TESA-blot
TESA-blotting was performed at the São Paulo Institute for 
Tropical Medicine (IMTSP) – USP following a published protocol 
(UMEZAWA et al., 1996, 2001). The TESA protein components 
were separated by SDS-PAGE (TOWBIN et al., 1979) in a 7% 
gel, and the proteins were transferred to a 0.45 mm nitrocellulose 
(NTC) membrane. After blocking the NTC membrane with 5% 
skim milk, the membrane containing the antigen was cut into 
5- mm strips that were incubated with dog sera (1:100). The 
complex was formed by adding peroxidase-conjugated dog anti-IgG 
(Sigma Co, EUA) and visualized by adding a developing solution 
(6 mg 4-chloronaphthol, 2 mL methanol, 10 mL PBS, and 10 µL 
H2O2). After bands appeared, the reaction was stopped by adding 
distilled water and recorded by digital photo documentation. 
The following proteins were used as molecular weight standards 
(Sigma Co, USA): carbonic anhydrase (29 kDa), egg albumin 
(45 kDa), bovine albumin (66 kDa), phosphorylase B (97 kDa), 
galactosidase (116 kDa), and myosin (205 kDa).
Statistical analysis
The inter-assay agreement (Kappa statistic) was calculated 
using the EpiInfo 6.04 program, with ELISA as the gold standard.
Results
The positive detection rate for anti-L. chagasi IgG antibodies 
by IIFA (LACEN-Araguaína) was 54.95% (61/111) and 51.35% 
(57/111) by ELISA (IMTSP-USP) (Figure 1). Figure 1 shows that 
14.8% (9/61) of samples that were positive by IIFA-LACEN were 
negative by ELISA-São Paulo, and 10% (5/50) of samples that 
were negative by IIFA were positive by ELISA. The inter-assay 
Kappa coefficient of agreement was 0.74. Table 1 lists differences 
in the results obtained by both of the methods applied.
Study of the anti-T. cruzi IgG antibodies revealed that 4.5% 
(5/111) of the samples were positive by TESA-blot (Figure 2). 
Four out of the five dogs suspected of infection by T. cruzi were 
also positive by ELISA for diagnosis of leishmaniasis, while three 
of the canines were negative by IIFA (Figure 1). Only one animal 
was considered co-infected with Leishmania spp. The reactivity 
profile of these samples by TESA-blot was quantitatively lower 
than the reactivity of dogs known to have CD (Figure 2, row 6).
Discussion
VL is a chronic disease that is fatal in both humans and dogs. 
The clinical diagnosis is complex and should be performed using a 
Table 1. Comparison of the results from L. chagasi IIFA performed 
in Araguaína and ELISA performed in São Paulo.
IIFA-Araguaína
ELISA-São Paulo
Total
Positive Negative
Positive 52 9 61
Negative 5 45 50
Total 57 54 111
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combination of serological, parasitological, and/or molecular tests 
(SILVA, 2007). According to a study conducted by Bevilacqua et al. 
(2001), CVL precedes human cases because the spatial and 
chronological distribution of canine cases in the city of Belo 
Horizonte – MG has occurred much earlier than reports of 
human cases. Therefore, dogs are considered the main reservoir 
of the disease for humans. This finding highlights the importance 
of CVL in Araguaína due to the high regional prevalence of dogs 
seropositive for L. chagasi. Of the 5,183 canine samples analyzed 
in 2010, 2,544 (49.08%) were diagnosed as positive for CVL by 
IIFA (LACEN/TO, 2010).
VL and CD are serious public health problems in endemic and 
epidemic areas where these diseases coexist due to individual and 
environmental risk factors such as mass migration, urbanization, 
and deforestation. In addition, dogs are a domestic reservoir for 
both diseases (BRASIL, 2006; RIBEIRO, 2010). The high rate of 
positivity for CVL (51.35%) found by ELISA in the present study 
was much higher than the rates of 30.67% and 37.3% reported 
in Dourados – MS (MARCONDES, 2009) and Cuiabá – MT 
(ALMEIDA et al., 2010), respectively. This finding stresses the 
importance of accurate disease diagnosis because cross-reactivity 
is possible.
TESA-blotting was used to study anti-T. cruzi antibodies. 
This assay consists of a WB prepared using exoantigens from 
trypomastigotes of T. cruzi strain Y, which is considered positive 
when a 150-kDa band appears. This method has 100% sensitivity 
and specificity, does not suffer cross-reactivity, permits differentiation 
between the acute and chronic phases of CD, and is considered 
a confirmatory test when conventional serological results are 
inconclusive (UMEZAWA et al., 1996; NAKAZAWA et al., 2001; 
SILVA, 2007). In the present study, anti-T. cruzi antibodies were 
found in 4.5% (5/111) of the analyzed canine serum samples. 
Although lower than the 10.7% rate reported by Souza (2007) in 
Mato Grosso do Sul, the rate reported herein indicated the presence 
of dogs with CD in the region endemic for CVL. It should be 
noted that four of the samples positive for CD by TESA-blot were 
reactive on ELISA, and three were non-reactive by IIFA. This finding 
demonstrates the lack of cross-reactivity between L. chagasi and 
T. cruzi by IIFA. Similar findings were reported by Rosypal et al. 
(2007), who analyzed dog sera from Colombia (n=258) and São 
Paulo (n=107) and found no positivity for T. cruzi by IIFA among 
samples that were seropositive for L. chagasi. In the present study, 
only one dog exhibited reactivity on the applied assays and was 
considered co-infected by both diseases. This finding suggests the 
involvement of that dog in the epidemiology of CD in Araguaína.
The results obtained in the present study suggest that dogs 
diagnosed as seroreactive for L. chagasi by IIFA have CVL, even 
if clinical changes are not yet apparent. It is evident that the 
canine population in Araguaína may be simultaneously infected 
with L. chagasi and T. cruzi. Therefore, a broad epidemiological 
assessment is necessary, especially in areas where the diseases are 
endemic. The Kappa coefficient showed moderate agreement 
between IIFA and ELISA for CVL diagnosis. The samples that 
diverged suggest a requirement for a combination of diagnostic 
methods to confirm leishmaniasis in dogs.
Conclusions
The present study demonstrated the lack of cross-reactivity 
between L. chagasi and T. cruzi by IIFA; however, cross-reactivity 
was detectable when using ELISA, which uses the soluble protein 
antigen extract from L. chagasi promastigotes. Additionally, the 
recognition of anti-T. cruzi antibodies suggests involvement of 
the dog in the epidemiology of CD in Araguaína.
References
Almeida ABPF, Mendonça AJ, Sousa VRF. Prevalência e epidemiologia 
da Leishmaniose Visceral em cães e humanos, na cidade de Cuiabá, 
Mato Grosso, Brasil. Cienc Rural 2010; 40(7): 1610-1615. http://dx.doi.
org/10.1590/S0103-84782010005000102
Alves WA, Bevilacqua PD. Reflexões sobre a qualidade do diagnóstico 
da leishmaniose visceral canina em inquéritos epidemiológicos: o caso 
da epidemia de Belo Horizonte, Minas Gerais, Brasil, 1993-1997. Cad 
Saúde Pública 2004; 20(1): 259-265. PMid:15029328. http://dx.doi.
org/10.1590/S0102-311X2004000100043
Figure 1. ELISA results for analysis of anti-L. chagasi IgG antibodies 
in dogs from Araguaína – TO that were positive and negative by 
IIFA. The shaded area represents samples considered non-reactive.
Figure 2. Reactivity profile of the TESA-blot for the detection of 
T. cruzi infection in dogs from Araguaína – TO. 1-5: positive samples; 
6: positive control from a dog with CD; 7: negative control from a 
dog without CD.
228
Canine leishmaniasis and Chagas disease in Araguaina
Assis J, Queiroz MGP, Silveira RCV, Nunes CM, Oliveira TMFS, 
Noronha ACFJ,  et  al. Estudo comparativo dos métodos diagnósticos 
para Leishmaniose Visceral em cães oriundos de Ilha Solteira, SP. Rev 
Bras Parasitol 2010; 19(1): 17-25.
Barata RA, França-Silva JC, Mayrink W, Silva JC, Prata A, Lorosa 
ES, et al. Aspectos da ecologia e do comportamento de flebotomíneos em 
área endêmica de leishmaniose visceral, Minas Gerais. Rev Soc Bras Med 
Trop 2005; 38(5): 421-425. PMid:16172760. http://dx.doi.org/10.1590/
S0037-86822005000500012
Bevilacqua PD, Paixão HH, Modena CM, Castro MCPS. Urbanização 
da Leishmaniose Visceral em Belo Horizonte. Arq Bras Med 
Vet Zootec  2001;  53(1):  1-8. http://dx.doi.org/10.1590/S0102-
09352001000100001
Bisugo MC, Araújo MFL, Taniguchi HH, Acunha E, Santos AA, 
Spessoto JM, et al. Avaliação do diagnóstico da Leishmaniose Visceral 
Canina com a utilização do teste rápido com antígeno recombinante 
K39 em regiões endêmicas do Estado de São Paulo. Rev Inst Adolfo 
Lutz 2007; 66(2): 185-193.
Borges BKA, Silva JA, Haddad JPA, Moreira EC, Magalhães DF, Ribeiro 
LML, et al. Presença de animais associada ao risco de transmissão da 
leishmaniose visceral em humanos em Belo Horizonte, Minas Gerais. Arq 
Bras Med Vet Zootec 2009; 61(5): 1035-1043. http://dx.doi.org/10.1590/
S0102-09352009000500004
Brasil. Ministério da Saúde. Departamento de Vigilância Epidemiológica. 
Secretaria de Vigilância em Saúde. Manual de Vigilância e Controle da 
Leishmaniose Visceral. Brasília: Ministério da Saúde;  2006. Available 
from: http://portal.saude.gov.br/portal/arquivos/pdf/manual_leish_
visceral2006.pdf
Brasil. Ministério da Saúde. DATASUS – Departamento de Informática 
do SUS. Leishmaniose visceral – Casos confirmados Notificados no Sistema 
de Informação de Agravos de Notificação – Sinan Net. Brasília: Ministério 
da Saúde; 2010. Available from: http://dtr2004.saude.gov.br/sinanweb/
tabnet/dh?sinannet/leishvi/bases/leishvbrnet.def.
Cohen JE, Gurtler RE. Modeling household transmission of American 
trypanosomiasis. Science 2001; 293(5530): 694-698. PMid:11474111. 
http://dx.doi.org/10.1126/science.1060638
Dietze R, Carvalho SFG. Leishmaniose visceral – calazar. In: Cemerman 
S, Cimerman B. (Ed). Medicina tropical. São Paulo: Atheneu;  2003. 
p. 65-84.
Correa VR. Avaliação e epidemiologia da cardiopatia Chagásica em pacientes 
atendidos em Araguaína-Tocantins. [Dissertação]. São Paulo: Instituto de 
Pesquisas Energéticas e Nucleares; Universidade de São Paulo; 2010.
Feitosa MM, Ikeda FA, Luzivotto MCR, Perri SHV. Aspectos Clínicos 
de cães com Leishmaniose Visceral no município de Araçatuba - São 
Paulo (Brasil). Clin Vet 2000; 28: 36-44.
Gomes YM. Doença de Chagas, Diagnóstico laboratorial - situação atual. 
Fundação Oswaldo Cruz-FIOCRUZ;  2004. [cited  2010 Dec  20]. 
Available from: http://www.fiocruz.br/chagas/cgi/cgilua.exe/sys/start.
htm?sid=102.
Gontijo CMF, Melo MN. Leishmaniose visceral no Brasil: quadro atual, 
desafios e perspectivas. Rev Bras Epidemiol 2004; 7(3): 338-349. http://
dx.doi.org/10.1590/S1415-790X2004000300011
Laboratório Central de Saúde Pública do Tocantins – LACEN/TO. 2010.
Luciano RM, Lucheis SB, Troncarelli MZ, Luciano DM, Langoni 
H. Avaliação da reatividade cruzada entre antígenos de Leishmania 
spp e Trypanosoma cruzi na resposta sorológica de cães pela técnica 
de imunofluorescência indireta (RIFI). Braz J Vet Res Anim 
Sci 2009; 46(3): 181-187.
Lutz A, Neiva A. Contribuição para o conhecimento das especies 
do gênero  Phlebotomus  existentes no Brasil.  Mem Inst Oswaldo 
Cruz  1912;  4(1):  84-95. http://dx.doi.org/10.1590/S0074-
02761912000100006
Marcondes E. Avaliação dos dados epidemiológicos de Leishmaniose Visceral 
canina na cidade de Dourados, estado de Mato Grosso do Sul. [online]. 2009 
[cited  2010 Dec  20]. Available from: http://www.webartigos.com/
articles/29960/1/.
Monteiro MEZ, Baruque M, Neves MF. Leishmaniose Visceral 
em cães: Relato de caso. Revista Científica Eletrônica de Medicina 
Veterinária 2009; 7(12): 1-5.
Nakazawa M, Rosa DS, Pereira VRA, Moura MO, Furtado VC, 
Souza WV, et al. Excretory-secretory antigens of Trypanosoma cruzi are 
potentially useful for serodiagnosis of chronic Chagas’ disease. Clin Diagn 
Lab Immunol 2001; 8(5): 1024-1027. PMid:11527823 PMCid:96191.
Pedroso TC. Diagnóstico da Leishmaniose Visceral Canina.[ online]. 2010 
[cited 2010 Dec 29]. Available from: https://www.portaleducacao.com.
br/veterinaria/artigos/9948/diagnostico-da-leishmaniose-visceral-canina.
Pinto P. Diagnóstico preciso para a doença de chagas. [online].  2009 
[cited 2010 Dec 13]. Available from: www.fiocruz.br.
Rey L. Parasitologia: parasitos e doenças parasitárias do homem nos trópicos 
ocidentais. 4. ed. Rio de Janeiro: Guanabara Koogan; 2008.
Ribeiro LML. Análise do conhecimento, sobre Leishmaniose Visceral e outras 
zoonoses, de docentes dos três primeiros anos do ensino fundamental em escolas 
da região noroeste de Belo Horizonte, Minas Gerais, 2008 [Dissertação]. 
Belo Horizonte: Universidade Federal de Minas Gerais; 2010.
Rosypal AC, Cortés-Vecino JA, Gennari SM, Dubey JP, Tidwell 
RR, Lindsay DS. Serological survey of Leishmania infantum and 
Trypanosoma cruzi in dogs from urban areas of Brazil and Colombia. 
Vet Parasitol 2007; 149: 172-177. PMid:17825991 PMCid:2238727. 
http://dx.doi.org/10.1016/j.vetpar.2007.08.004
Santos SO, Arias J, Ribeiro AA, Hoffmann MP, Freitas RA, Malacco 
MAF. Incrimination of Lutzomyia cruzi as a vector of American visceral 
leishmaniasis. Med Vet Entomol 1998; 12(3): 315-317. PMid:9737605. 
http://dx.doi.org/10.1046/j.1365-2915.1998.00104.x
Silva FS. Patologia e patogênese da leishmaniose visceral canina. Rev Trop 
Cienc Agr Biol 2007: 1(1): 20-31.
Souza AI. Estudo clínico da infecção natural por T. cruzi em cães residentes em 
um área rural de Mato Grosso do Sul-Brasil [Tese]. São Paulo: Universidade 
Estadual Paulista; 2007.
Sundar S, Rai M. Laboratory diagnosis of visceral leishmaniasis. 
Clin DiagnLab Immunol  2002;  9(5):  951-958. PMid:12204943 
PMCid:120052.
Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of 
proteins from polyacrylamide gels to nitrocellulose sheets: Procedure 
and some applications. Proc Natl Acad Sci USA  1979;  76(9):  4350-
4354. PMid:388439 PMCid:411572. http://dx.doi.org/10.1073/
pnas.76.9.4350
Umezawa ES, Nascimento MS, Stolf AM. Enzyme-linked immunosorbent 
assay with Trypanosoma cruzi excreted-secreted antigens (TESA-ELISA) 
for serodiagnosis of acute and chronic Chagas’s disease. Diagn Microbiol 
Infect Dis  2001;  39(3):  169-176. http://dx.doi.org/10.1016/S0732-
8893(01)00216-4
Umezawa ES, Nascimento MS, Kersper N Jr, Coura JR, Borges-Pereira 
J, Junqueira ACV,  et  al. Immunoblot assay using excreted-secreted 
antigens of Trypanosoma cruzi in serodiagnosis of congenital, acute, 
and chronic Chagas’ disease. J Clin Microbiol 1996; 34(9): 2143-2147. 
PMid:8862574 PMCid:229206.
v. 22, n. 2, abr.-jun. 2013 229
